Affinity Asset Advisors, LLC Geron Corp Put Options Transaction History

Affinity Asset Advisors, LLC

2 transactions

Quarter	Operation	Price Per put	puts change	puts Held	SEC Form
Q4 2022 Feb 13, 2023	BUY	$2.03 - $2.42 $825,194 - $983,730	406,500 Added 62.54%	1,056,500 $2.56 Million
Q3 2022 Nov 14, 2022	BUY	$1.67 - $2.94 $1.09 Million - $1.91 Million	650,000 New	650,000 $1.52 Million

275

491M

1.87M

690K

Ticker GERN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 377,819,008
Market Cap $1.51B
Description
Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...

Get notified when there are updates to the investment portfolio of Affinity Asset Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Affinity Asset Advisors, LLC with notifications on news.